MissionIR Articles

Helix BioPharma Corp., a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, has filed a clinical trial application (CTA) in both Germany and the United Kingdom, with the Bundesinstitut für Arzneimittel…

Albany Molecular Research, reflecting the ongoing challenges of the global economy, announced today a series of cost saving actions for 2012, including a reduction in the company’s workforce. The moves are designed to improve AMRI’s…

Today, Granite City Food & Brewery Ltd. announced that it completed the purchase of assets belonging to the Cadillac Ranch All American Bar & Grill restaurant in Miami, Florida. The Miami restaurant is located in…

San Francisco based Rackwise, Inc., provider of software for the rapidly growing market of Data Center Infrastructure Management (DCIM), has executed a series of agreements with Intel Corporation to affect a master license for the…

Capstone Turbine, the world’s leading clean technology manufacturer of microturbine energy systems, today announced that they have inked a deal for three Capstone C1000 microturbines that will provide three megawatts of clean power to an…

Today, China TechFaith Wireless Communication Technology Ltd. announced that the Shenyang Government has granted approval for the company to acquire approximately 11.5 acres in Shenyang City’s Shenbei New District. TechFaith will use the property to…

Today, Repligen Corp., already leading with a strong presence in critical components used in the manufacture of biologic drugs, announced they are taking development of their SecreFlo™ hormone, designed for use as an imaging enhancer…

Liberty Silver Corp., a company focused on exploring and developing mineral properties in North America, today announced it has closed a $4.6 million funding. The company also announced its acceptance for listing on the Toronto…

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases afflicting the Chinese population. The company announced today that its newly acquired…

Through a full suite of investor relations services, MissionIR is able to custom tailor the most effective communication strategy for its clients. By utilizing a comprehensive database, MissionIR strategically matches those clients with brokers, hedge…

Noble Financial Capital Markets will be presenting its eighth annual BOCEMb equity conference at the Hard Rock Hotel & Casino in Hollywood (Ft. Lauderdale), Florida, January 17-18, 2012. The conference will feature approximately 140 public…

Leading molecular diagnostics company, Vermillion, Inc., announced today that it has completed purchasing almost all of the assets associated with Correlogic Systems, Inc., the ovarian cancer diagnostics business. Before filing for bankruptcy protection under Chapter…

Today, private company BI-LO, LLC, operator of some 207 supermarkets and 116 in-store pharmacies in the US SE market, and Winn-Dixie Stores, Inc. (WINN), with their fleet of some 480 supermarkets/380 in-store pharmacies, announced a…

Genetic Technologies Ltd., a leading-edge genetic testing and fertility services business from Australia that has an extensive range of international patents and allied research activities aimed at uncovering the impact of DNA on health, recently…

Noble Financial Capital Markets, with offices around the country, defines itself as a full-service investment banking boutique, focused on private, micro-cap and small-cap emerging growth companies, with a special emphasis on Healthcare and Technology sectors.…

Biopharmaceutical company Chelsea Therapeutics International Ltd. today announced it has received allowance from the U.S. Patent & Trademark Office (USPTO) for its patent application “Threo-DOPS Controlled Release Formulation.” This marks the second major milestone for…